NCT05779423View on ClinicalTrials.gov

Cryoablation+Ipilimumab+Nivolumab in Melanoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 23, 2023

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions
Metastatic MelanomaSkin Cancer
Interventions
DRUG

Ipilimumab

Monoclonal antibody administered through intravenous infusion

DRUG

Nivolumab

Monoclonal antibody administered through intravenous infusion

PROCEDURE

Cryoablation

Procedure of freezing a tumor performed via CT-guidance by interventional radiologist.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER